Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kane Biotech's share price for the quarter that ended in Mar. 2024 was C$0.1. Kane Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 131.85 Mil. Therefore, Kane Biotech's market cap for the quarter that ended in Mar. 2024 was C$13.18 Mil.
Kane Biotech's quarterly market cap
increased
from Sep. 2023 (C$9.89 Mil) to Dec. 2023 (C$10.55 Mil) and
increased
from Dec. 2023 (C$10.55 Mil) to Mar. 2024 (C$13.18 Mil).
Kane Biotech's annual market cap
declined
from Dec. 2021 (C$17.80 Mil) to Dec. 2022 (C$11.23 Mil) and
declined
from Dec. 2022 (C$11.23 Mil) to Dec. 2023 (C$10.55 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kane Biotech's Enterprise Value for Today is C$24.27 Mil.
Kane Biotech Market Cap Historical Data
The historical data trend for Kane Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kane Biotech's Market Cap
For the Biotechnology subindustry, Kane Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kane Biotech's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kane Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Kane Biotech's Market Cap falls into.
Kane Biotech Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kane Biotech's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kane Biotech (TSXV:KNE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kane Biotech Market Cap Related Terms
Thank you for viewing the detailed overview of Kane Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:KNE has been successfully added to your 